Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Infographics

Nuclear stress tests expose patients to toxic radiation levels. We found 18 percent of physicians order them over 75 percent of the time.

Medical Director, CARDS, Providence St. Joseph Health
Principal, Oliver Wyman
Senior Consultant, Oliver Wyman
Consultant, Oliver Wyman

They Just Have to Persuade People to Like Them

Oliver Wyman research examines whether consumers are using healthcare’s “new front door”, and if not, why not.

Principal, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Q&A with the Academy of Nutrition and Dietetics on malnutrition's greatest challenges and opportunities

What if your doctor handed out grocery lists, not a grocery list of pills to take?

Principal, Oliver Wyman
Chief Science Officer, Academy of Nutrition and Dietetics

HMSA and Navvis Partner to Improve the Health of the People of Hawaii

Navvis and HMSA have designed a system ending fee-for-service and moving primary care physicians to a value-based payment model.

Executive Officer and President, Navvis
President and CEO, Hawaii Medical Service Association
Oliver Wyman Health, Editor

When it comes it health benefits, paying more doesn't always get you more. But, consumers will open up their wallets for better value.

Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Pharma companies and providers in search of better solutions must look to the patient experience for answers.

Partner, Digital & Analytics, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

A closer look at how fast change may happen, who could win (and lose), and how the next decade may unfold for incumbents and new market entrants.

Partner, Health & Life Sciences, Oliver Wyman
Senior Knowledge Expert, Health & Life Sciences, Oliver Wyman

Hospital systems seek sustainability, scale, and relevance. Models that rethink tradition will thrive.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

2018 was a big year for industry news. Here's what might happen next in artificial intelligence, the 2020 presidential election, pharma, and more.

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Despite its unstable global geopolitical climate, Asia is primed for steady change this year in healthcare.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Head of Health & Life Sciences, Asia Pacific, Oliver Wyman

Insights in your inbox

Subscribe